Literature DB >> 25434817

Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis.

Yongqing Liu1, Xiaoqin Lu2, Li Huang3, Wei Wang2, Guomin Jiang2, Kevin C Dean2, Brian Clem4, Sucheta Telang4, Alfred B Jenson4, Miriam Cuatrecasas5, Jason Chesney4, Douglas S Darling6, Antonio Postigo7, Douglas C Dean1.   

Abstract

Ras pathway mutation is frequent in carcinomas where it induces expression of the transcriptional repressor ZEB1. Although ZEB1 is classically linked to epithelial-mesenchymal transition and tumour metastasis, it has an emerging second role in generation of cancer-initiating cells. Here we show that Ras induction of ZEB1 is required for tumour initiation in a lung cancer model, and we link this function to repression Pten, whose loss is critical for emergence of cancer-initiating cells. These two roles for ZEB1 in tumour progression can be distinguished by their requirement for different levels of ZEB1. A lower threshold of ZEB1 is sufficient for cancer initiation, whereas further induction is necessary for tumour metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25434817     DOI: 10.1038/ncomms6660

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  25 in total

1.  Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles.

Authors:  Marlies Cortés; Lidia Sanchez-Moral; Oriol de Barrios; María J Fernández-Aceñero; M C Martínez-Campanario; Anna Esteve-Codina; Douglas S Darling; Balázs Győrffy; Toby Lawrence; Douglas C Dean; Antonio Postigo
Journal:  EMBO J       Date:  2017-10-16       Impact factor: 11.598

2.  Cutaneous Epithelial to Mesenchymal Transition Activator ZEB1 Regulates Wound Angiogenesis and Closure in a Glycemic Status-Dependent Manner.

Authors:  Kanhaiya Singh; Mithun Sinha; Durba Pal; Saba Tabasum; Surya C Gnyawali; Dolly Khona; Subendu Sarkar; Sujit K Mohanty; Fidel Soto-Gonzalez; Savita Khanna; Sashwati Roy; Chandan K Sen
Journal:  Diabetes       Date:  2019-08-22       Impact factor: 9.461

3.  ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.

Authors:  E Sánchez-Tilló; O de Barrios; E Valls; D S Darling; A Castells; A Postigo
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

4.  ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.

Authors:  Cody L Nesvick; Chao Zhang; Nancy A Edwards; Blake K Montgomery; Michaela Lee; Chunzhang Yang; Herui Wang; Dongwang Zhu; John D Heiss; Marsha J Merrill; Abhik Ray-Chaudhury; Zhengping Zhuang
Journal:  J Neurooncol       Date:  2016-08-27       Impact factor: 4.130

Review 5.  Epigenetically distinct sister chromatids and asymmetric generation of tumor initiating cells.

Authors:  Yongqing Liu; Laura Siles; Antonio Postigo; Douglas C Dean
Journal:  Cell Cycle       Date:  2018-10-13       Impact factor: 4.534

Review 6.  Non-redundant functions of EMT transcription factors.

Authors:  Marc P Stemmler; Rebecca L Eccles; Simone Brabletz; Thomas Brabletz
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

7.  Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.

Authors:  Mingyang Liu; Yuqing Zhang; Jingxuan Yang; Hanxiang Zhan; Zhijun Zhou; Yuanyuan Jiang; Xiuhui Shi; Xiao Fan; Junxia Zhang; Wenyi Luo; Kar-Ming A Fung; Chao Xu; Michael S Bronze; Courtney W Houchen; Min Li
Journal:  Gastroenterology       Date:  2021-01-06       Impact factor: 22.682

8.  Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells.

Authors:  Yan Guo; Xiaoqin Lu; Yao Chen; Beatriz Rendon; Robert A Mitchell; Miriam Cuatrecasas; Marlies Cortés; Antonio Postigo; Yongqing Liu; Douglas C Dean
Journal:  Sci Adv       Date:  2021-05-21       Impact factor: 14.136

Review 9.  Epithelial-Mesenchymal Transition-Inducing Factors Involved in the Progression of Lung Cancers.

Authors:  Min-Woo Nam; Cho-Won Kim; Kyung-Chul Choi
Journal:  Biomol Ther (Seoul)       Date:  2022-05-01       Impact factor: 4.634

Review 10.  Oncogenic functions of ZEB1 in pediatric solid cancers: interplays with microRNAs and long noncoding RNAs.

Authors:  Lívia Fratini; Mariane Jaeger; Caroline Brunetto de Farias; André T Brunetto; Algemir L Brunetto; Lisa Shaw; Rafael Roesler
Journal:  Mol Cell Biochem       Date:  2021-07-22       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.